Core Alternative Capital Johnson & Johnson Transaction History

Core Alternative Capital

$448 Million
Q4 2024

A detailed history of Core Alternative Capital transactions in Johnson & Johnson stock. As of the latest transaction made, Core Alternative Capital holds 57,736 shares of JNJ stock, worth $8.86 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares

57,736

Previous 60,171 4.05%

Holding current value

$8.86 Million

Previous $9.75 Million 14.38%

% of portfolio

1.86%

Previous 1.96%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$143.34 - $165.86 $349,032 - $403,869	-2,435 Reduced 4.05%	57,736 $8.35 Million
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $878,990 - $1.01 Million	-6,042 Reduced 9.13%	60,171 $9.75 Million
Q2 2024 Aug 16, 2024	SELL	$144.38 - $157.78 $1.21 Million - $1.33 Million	-8,414 Reduced 11.27%	66,213 $9.68 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $1.61 Million - $1.69 Million	-10,357 Reduced 12.19%	74,627 $11.8 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $2.95 Million - $3.22 Million	-20,275 Reduced 19.26%	84,984 $13.3 Million
Q3 2023 Oct 19, 2023	SELL	$155.75 - $174.48 $771,118 - $863,850	-4,951 Reduced 4.49%	105,259 $16.4 Million
Q2 2023 Jul 27, 2023	SELL	$154.35 - $166.11 $1.93 Million - $2.08 Million	-12,497 Reduced 10.18%	110,210 $18.2 Million
Q1 2023 Apr 18, 2023	SELL	$151.05 - $180.26 $56,643 - $67,597	-375 Reduced 0.3%	122,707 $19 Million
Q4 2022 Jan 31, 2023	BUY	$160.2 - $179.79 $3.69 Million - $4.14 Million	23,030 Added 23.02%	123,082 $21.7 Million
Q3 2022 Oct 18, 2022	BUY	$161.33 - $179.52 $6.55 Million - $7.29 Million	40,594 Added 68.27%	100,052 $16.3 Million
Q2 2022 Aug 01, 2022	BUY	$168.19 - $186.01 $1.7 Million - $1.88 Million	10,096 Added 20.45%	59,458 $10.6 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $1.37 Million - $1.56 Million	-8,688 Reduced 14.97%	49,362 $8.75 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $98,703 - $109,515	633 Added 1.1%	58,050 $9.59 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $1.11 Million - $1.23 Million	6,848 Added 13.54%	57,417 $9.27 Million
Q2 2021 Aug 05, 2021	BUY	$159.48 - $171.07 $1.4 Million - $1.5 Million	8,755 Added 20.94%	50,569 $8.33 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $341,499 - $380,340	2,231 Added 5.64%	41,814 $6.87 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $384,593 - $441,450	2,805 Added 7.63%	39,583 $6.23 Million
Q3 2020 Oct 09, 2020	SELL	$140.38 - $153.83 $472,799 - $518,099	-3,368 Reduced 8.39%	36,778 $5.48 Million
Q2 2020 Jul 13, 2020	SELL	$128.81 - $155.51 $549,503 - $663,405	-4,266 Reduced 9.61%	40,146 $5.65 Million
Q1 2020 Jun 09, 2020	BUY	$111.14 - $153.99 $3.2 Million - $4.44 Million	28,807 Added 184.6%	44,412 $5.82 Million
Q4 2019 Jun 05, 2020	BUY	$127.5 - $146.44 $1.99 Million - $2.29 Million	15,605 New	15,605 $2.28 Million

Others Institutions Holding JNJ

# of Institutions

4,350

Shares Held

1.69B

Call Options Held

17.7M

Put Options Held

14.6M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $401B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.

Account

Core Alternative Capital Johnson & Johnson Transaction History